Share price and RNS

To view the latest share price data and regulatory news service announcements for Sareum plc please click on the links below.

Sareum Holdings News and Articles from

Proactive Investors logo

RNS press release - Advisers
15th June 2018
Media files - Sareum Holdings says taking back control of cancer technology is “good news”
31st May 2018
News - Sareum Holdings takes back promising cancer technology
31st May 2018
Sareum Holdings Plc (LON:SAR) said it had regained the rights to a pre-clinical technology that may have the potential to treat acute myeloid leukaemia and other blood-borne cancers. The Aurora+FLT3 kinase inhibitors…
RNS press release - Sareum regains rights to Aurora+FLT3 inhibitors
31st May 2018
News - Sareum Holdings pleased as Sierra Oncology advances cancer drug trial
10th May 2018
Sareum Holdings PLC (LON:SAR) has highlighted the expansion of the patient cohort for a Phase 2 cancer drug trail being carried out by Sierra Oncology. NASDAQ-listed Sierra is the licence holder for Sareum intellectual property relating to cer…
50

Contact

Sareum Limited
Unit 2A, Langford Arch
London Road, Pampisford
Cambridge CB22 3FX
United Kingdom


tel: +44 (0) 1223 497700
fax: +44 (0) 1223 497701
email_white.png

Downloads

Half Year Results 2018 (0.9 MB) 

Annual report PDF 2017 (2.3MB)

   Annual Report 2017